Free Trial
One Day Left! MarketBeat All Access Returns to $249 Soon
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Don't Miss Out
Claim MarketBeat All Access Sale Promotion

Truist Financial's Rating of ArriVent BioPharma on 10/26/2026

On October 26, 2026, Truist Financial updated its outlook on ArriVent BioPharma (NASDAQ:AVBP) with the action "Set Price Target", setting a price target of $21.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Truist Financial Corporation

DateCompanyAction
10/29/2026
KLA Corporation stock logo
KLAC
KLA
Set Price Target
10/29/2026
CPB Inc. stock logo
CPF
CPB
Set Price Target
10/29/2026
Clean Harbors, Inc. stock logo
CLH
Clean Harbors
Set Price Target
10/29/2026
eBay Inc. stock logo
EBAY
eBay
Boost Price Target
10/29/2026
Microsoft Corporation stock logo
MSFT
Microsoft
Set Price Target
10/29/2026
Alphabet Inc. stock logo
GOOG
Alphabet
Set Price Target
More Ratings From Truist Financial Corporation